Perspective Therapeutics, Inc. — Director's Dealing 2021

Nov 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2021-11-23

Reporting Person: Woods Lori A (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-23	Common Stock	M	62500	$0.46	Acquired	909538	Indirect
2021-11-23	Common Stock	M	62500	$0.43	Acquired	972038	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-23	Stock Options (right to buy)	$0.46	M	62500	Disposed	2028-06-13	Common Stock (62500)	Direct
2021-11-23	Stock Options (right to buy)	$0.43	M	62500	Disposed	2029-06-18	Common Stock (62500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	48076	Direct

Footnotes

F1: 250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, 25% vested on 6/13/2020 and the remaining 25% vested on 6/13/2021. The shares exercised on 11/23/2021 represent the shares that vested on 6/13/2021.

F2: 250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% will vest on 6/18/2022. The shares exercised on 11/23/2021 represent the shares that vested on 6/18/2021.